SRPT Jan 2026 80.000 call
| Previous Close | 91.40 |
| Open | 95.55 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 80.00 |
| Expire Date | 2026-01-16 |
| Day's Range | 91.40 - 95.55 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 4 |
ZacksSarepta Therapeutics (SRPT) Soars 30.1%: Is Further Upside Left in the Stock?
Sarepta Therapeutics (SRPT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
- Yahoo Finance Video
What next for gas prices, how the S&P 500 can reach 6,000: Market Domination
It was a quiet Friday on Wall Street, with the three major indexes (^DJI,^GSPC, ^IXIC) closing relatively flat. On the latest episode of Market Domination, Evercore ISI's Julien Emmanuel explains why he raised his year-end price target for the S&P 500 to 6,000. RBC Capital Markets US Economist Michael Reid discussed what's next for the Federal Reserve, including why he thinks the economy is in for a period of "normalization." In the latest edition of Good Buy or Goodbye, Washington Crossing Advisors Senior Portfolio Manager Chad Morganlander explains why he is buying Tractor Supply (TSCO) but skipping Macy's (M). GasBuddy's Patrick DeHaan talks about what to expect for gas prices going into the Fourth of July travel period. Yahoo Finance's Julie Hyman and Jared Blikre also recap the latest news on Sarepta Therapeutics (SRPT), Palantir (PLTR), Smith & Wesson Brands (SWBI), and McDonald's (MCD). For more expert insight and the latest market action, click here. This post was written by Stephanie Mikulich.
